Resources Contact Us Home
Patterson; Adam Vorn
Auckland, NZ
No. of patents:

Patent Number Title Of Patent Date Issued
7776924 Nitroaniline-based alkylating agents and their use as prodrugs August 17, 2010
Nitroaniline-based unsymmetrical mustards of the general formula (I) are provided, together with methods of preparation and methods for their use as prodrugs for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia
7718688 Nitrobenzindoles and their use in cancer therapy May 18, 2010
The present invention relates generally to nitro-1,2-dihydro-3H-benzo[e]indoles and related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.
7629332 Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and the December 8, 2009
The present invention relates to a novel nitrophenyl mustard and nitrophenylaziridine alcohols, to their corresponding phosphates, to their use as targeted cytotoxic agents; as bioreductive drugs in hypoxic tumors, and to their use in cell ablation, including gene-directed enzyme-pro

  Recently Added Patents
Systems and methods for tracking power modulation
Motor vehicle, toy and/or replica
Preserving privacy of digital communication information
Real-time application of filters based on image attributes
Backside structure and methods for BSI image sensors
Method and system for modularized configurable connector system for ethernet applications
Power converter and method of power conversion
  Randomly Featured Patents
Monitoring system for motors
Thermal transfer printer including control of relative rates of speed of feeding of ink sheet and recording paper based on corrected count of gradation pulses
Laser-assisted cutting device
Convertible earhook headset
Collagenous dressing
Printer driver identification for a remote printer
Glycoproteins which bind to TNF
Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
Stable shaped particles of crystalline organic compounds
Electronic timepiece having improved primary frequency divider response characteristics